Dr Lal Pathlabs on Tuesday reported a net profit of Rs 72.4 crore for the July-September period, down 24.8 percent compared with the corresponding period a year ago. The share of COVID-related operations shrank to 3.7 percent from 10.1 percent in the three-month period compared to the year-ago quarter.
The diagnostic company's total revenue increased 7.1 percent on a year-on-year basis to Rs 533.8 crore, according to a regulatory filing.
Revenue from non-COVID operations increased 14.8 percent on year to Rs 514 crore, and that from COVID and the allied services slumped 61.3 percent to Rs 19.6 crore.
The company's EBITDA margin — or the degree to which a business earns money — came down to 26.4 percent in the July-September period from 28.4 percent in the year-ago period.
Revenue in the six months to September 2022 came in at Rs 1,036.5 crore, as against Rs 1,105 crore for the year-ago period.
Dr Lal said the results for the six-month period were not strictly comparable with the year-ago period due to the resurgent COVID·19 wave in the April-June period.
Dr Lal Pathlabs shares ended higher by Rs 46 or 1.8 percent at Rs 2,625.6 apiece on BSE.
Dr Lal Pathlabs shares have rewarded investors with a return of 10.6 percent in the past one month — a period in which the Nifty50 benchmark has gained five percent of value.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha Election 2024 — how regional parties are challenging national giants in Phase-4
May 15, 2024 6:17 AM
Supreme Court refuses plea seeking 6-year poll ban on PM
May 14, 2024 7:14 PM
Punjab Lok Sabha elections 2024: A look at BJP candidates
May 14, 2024 7:06 PM
Lok Sabha polls: EC disposes of 90% complaints related to MCC violations
May 14, 2024 4:45 PM